GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Proteomics International Laboratories Ltd (ASX:PIQ) » Definitions » Common Stock

Proteomics International Laboratories (ASX:PIQ) Common Stock : A$36.81 Mil (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Proteomics International Laboratories Common Stock?

Proteomics International Laboratories's quarterly common stock increased from Dec. 2023 (A$30.80 Mil) to Jun. 2024 (A$36.81 Mil) but then declined from Jun. 2024 (A$36.81 Mil) to Dec. 2024 (A$36.81 Mil).

Proteomics International Laboratories's annual common stock increased from Jun. 2022 (A$19.34 Mil) to Jun. 2023 (A$30.18 Mil) and increased from Jun. 2023 (A$30.18 Mil) to Jun. 2024 (A$36.81 Mil).


Proteomics International Laboratories Common Stock Historical Data

The historical data trend for Proteomics International Laboratories's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proteomics International Laboratories Common Stock Chart

Proteomics International Laboratories Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.39 19.10 19.34 30.18 36.81

Proteomics International Laboratories Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.13 30.18 30.80 36.81 36.81

Proteomics International Laboratories Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Proteomics International Laboratories Business Description

Traded in Other Exchanges
Address
6 Verdun Street, QEII Medical Centre, QQ Block, Nedlands, Perth, WA, AUS, 6009
Proteomics International Laboratories Ltd is a biological research and drug discovery company. The company specializes in the area of proteomics which is the industrial-scale study of the structure and function of proteins. Its operations are divided into PromarkerD which targets the diabetes epidemic and is a predictive diagnostic test for diabetic kidney disease, a progressive disorder found in one in three adults with diabetes; its proprietary biomarker discovery platform called Promarker, which searches for protein fingerprints in a sample; and Analytical Services that are specialist contract research focusing on biosimilars quality control and pharmacokinetic testing for clinical trials.

Proteomics International Laboratories Headlines

No Headlines